Phibro Animal Health (PAHC) Tops Q2 EPS by 11c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Phibro Animal Health Corp. (PAHC) PT Raised to $22 at Barclays
February 7, 2025 2:18 PM ESTBarclays analyst Balaji Prasad raised the price target on Phibro Animal Health Corp. (NASDAQ: PAHC) to $22.00 (from $20.00) while maintaining a Underweight rating.
The analyst comments "2QFY25 Rev / Adj. EPS beat cons by ~2%/~25%. Growth was led by AH (+11% excl. new MFA; +33%... More
